A man from Lucknow appealed to the Russian government for his son to join Russia’s promising cancer vaccine trial after Indian doctors showed limited response.
The Russian government took a sensitive stand to an appeal made by Lucknow resident Manu Srivastava, who sought help to save the life of his 21-year-old son, Ansh Srivastava, who is battling cancer.
Manu Srivastava had requested the Russian government to conduct its vaccine trial on his son, as the vaccine in Russia was not available in India.
While speaking to ANI, Manu said that his son battling cancer that has now advanced to the fourth stage which is at its fourth stage. He said that although his son is being treated in India, the doctors haven’t been fully responsive. He then wrote to both the Government of India and the Russian government after learning that a new vaccine had been developed in Russia, proving very effective in treating cancer.
“When I learned that a vaccine had been developed in Russia, proving very effective in treating cancer, I sent letters to the Government of India and the Russian government. The reply came back saying my request was under consideration and the Russian government had sent it to their Ministry of Health for further processing,” he told ANI.
“We also wrote to the Indian government. A letter came from there as well. It stated that the vaccine, currently manufactured in Russia, is being implemented only in Russia. The people conducting the trials are local. So, we, and no other country, have yet received approval to conduct trials,” he added.